We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Forest Executives Win Battle Against Shareholders

Law360 (September 20, 2006, 12:00 AM EDT) -- A federal judge has dismissed a derivative lawsuit that accused certain Forest Laboratories Inc. executives of misleading shareholders about their main products, the blockbuster antidepressant drugs Celexa and Lexapro.

In his opinion, Judge Richard J. Holwell of the U.S. District Court in Manhattan did not deal directly with the shareholders’ complaints. Instead, he ruled that the plaintiffs were not entitled to bring an action in the name of the company against Forest’s board of directors and other executives.

“Cursory allegations that a director made sales of...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.